Skip to content
value.today

DyaMX, Inc.

🇺🇸 Plymouth, Minnesota, USAHealth CareFounded 2017
Total raised
$185 M
5 rounds on record
Latest round
$132 M
Jun 2024
First round on record
Nov 2018
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of DyaMX, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2024$132 MNo. 5$50 to $250 million

DyaMX, Inc.: Raise no. 5, Jun 2024

Investors in this round

16 investors had bought by the notice of Nov 6, 2026: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$132 M of $145 M offered; $12 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Krissy Wright · Executive Officer
  • Stacey Pugh · Executive Officer, Director
  • Doug Reed · Director
  • Gerald Brunk · Director
  • James Eadie · Director
  • Juliet Bakker · Director
  • Thomas Shehab · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “$132,351,878.51 was sold in an initial closing and subsequent closings of the offering and an additional $12,203,155.49 may be sold upon the achievement of milestones or the occurrence of certain events.”

Signed by Stacey Pugh, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Nov 6, 2026. Read the notice at the SEC.

equitySEC
Oct 2023$18 MNo. 4$10 to $50 million

DyaMX, Inc.: Raise no. 4, Oct 2023

Investors in this round

9 investors had bought by the notice of Oct 17, 2023: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $18 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them, other: Convertible Notes and Warrants for Next Round Securities or Series B-1 Preferred Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Stacey Pugh · Executive Officer, Director
  • Gerald Brunk · Director
  • James Eadie, M.D. · Director
  • Jeffrey Terrell · Director
  • John Deedrick · Director
  • Juliet Bakker · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stacey Pugh, Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 17, 2023. Read the notice at the SEC.

equity, optionsSEC
Feb 2023$9 MNo. 3$2 to $10 million

DyaMX, Inc.: Raise no. 3, Feb 2023

Investors in this round

7 investors had bought by the notice of Feb 24, 2023: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $13 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them, other: Series B-1 Preferred Stock and conversion of certain convertible promissory notes to Common Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Stacey Pugh · Executive Officer, Director
  • James Eadie, M.D. · Director
  • John Deedrick · Director
  • Juliet Bakker · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stacey Pugh, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 24, 2023. Read the notice at the SEC.

equitySEC
Apr 2021$12 MNo. 2$10 to $50 million

DyaMX, Inc.: Raise no. 2, Apr 2021

Investors in this round

7 investors had bought by the notice of Apr 20, 2021: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $12 M offered
Smallest investment taken
$37,884
What was sold
equity
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Paul Hindrichs · Executive Officer, Director
  • Robert Kukujlan · Executive Officer
  • James Eadie · Director
  • John Deedrick · Director
  • Juliet Bakker · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Paul Hindrichs, President & CEO. Source: SEC Form D, newest notice filed Apr 20, 2021. Read the notice at the SEC.

equitySEC
Nov 2018$13 MNo. 1$10 to $50 million

DyaMX, Inc.: Raise no. 1, Nov 2018

Investors in this round

6 investors had bought by the notice of Dec 6, 2018: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $13 M offered
Smallest investment taken
$42,549
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$525,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Deedrick · Executive Officer, Director
  • Michael Brenzel · Executive Officer
  • Paul Hindrichs · Executive Officer, Director
  • Robert Kukuljan · Executive Officer
  • James Eadie · Director
  • Juliet Bakker · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert Kukuljan, Secretary. Source: SEC Form D, newest notice filed Dec 6, 2018. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • DyaMX, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2026).

    SEC Form D · Nov 2026

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Nov 2026

That is all the official record says: DyaMX, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of DyaMX, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 16 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by DyaMX, Inc.
NameRoleNamed in
Krissy WrightExecutive officerNov 2026
Stacey PughExecutive officerJun 2024
Paul HindrichsExecutive officerApr 2021
Robert KukujlanExecutive officerApr 2021
John DeedrickExecutive officerDec 2018
Michael BrenzelExecutive officerDec 2018
Robert KukuljanExecutive officerDec 2018
Doug ReedDirectorNov 2026
Thomas ShehabDirectorNov 2026
Gerald BrunkDirectorJun 2024
James EadieDirectorJun 2024
Jeffrey TerrellDirectorJun 2024
Juliet BakkerDirectorJun 2024
Stacey PughDirectorJun 2024
James Eadie, M.D.DirectorOct 2023
John DeedrickDirectorOct 2023
Paul HindrichsDirectorApr 2021